Senseonics Holdings Cash Flow from Investing Activities 2015-2026 | SENS
Senseonics Holdings cash flow from investing activities from 2015 to 2026. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
|
Senseonics Holdings Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2025 | $-53 |
| 2024 | $33 |
| 2023 | $90 |
| 2022 | $27 |
| 2021 | $-149 |
| 2020 | $0 |
| 2019 | $-1 |
| 2018 | $19 |
| 2017 | $-13 |
| 2016 | $-8 |
| 2015 | $0 |
| 2014 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.266B | $0.035B |
| Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.880B | 26.54 |
| Tempus AI (TEM) | United States | $8.592B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $7.763B | 279.50 |
| Hinge Health (HNGE) | United States | $5.328B | 0.00 |
| 10x Genomics (TXG) | United States | $4.182B | 0.00 |
| Doximity (DOCS) | United States | $3.670B | 19.30 |
| IRhythm Holdings (IRTC) | United States | $3.440B | 0.00 |
| Privia Health (PRVA) | United States | $2.960B | 146.81 |
| Heartflow (HTFL) | United States | $2.918B | 0.00 |
| Clover Health Investments (CLOV) | United States | $2.707B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.851B | 0.00 |
| Omnicell (OMCL) | United States | $1.759B | 35.81 |
| Enovis (ENOV) | United States | $1.226B | 6.30 |
| Inspire Medical Systems (INSP) | United States | $1.191B | 16.03 |
| Schrodinger (SDGR) | United States | $1.124B | 0.00 |
| Azenta (AZTA) | United States | $1.026B | 49.49 |
| Talkspace (TALK) | United States | $0.873B | 521.00 |
| Veradigm (MDRX) | United States | $0.612B | 0.00 |
| Phreesia (PHR) | United States | $0.551B | 31.86 |
| Fulgent Genetics (FLGT) | United States | $0.507B | 0.00 |
| Evolent Health (EVH) | United States | $0.504B | 0.00 |
| Claritev (CTEV) | United States | $0.485B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.448B | 0.00 |
| TruBridge (TBRG) | United States | $0.392B | 11.35 |
| CapsoVision (CV) | United States | $0.324B | 0.00 |
| Standard BioTools (LAB) | United States | $0.302B | 0.00 |
| Carlsmed (CARL) | United States | $0.268B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.177B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.174B | 0.00 |
| American Well (AMWL) | United States | $0.136B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.127B | 0.00 |
| Outset Medical (OM) | United States | $0.090B | 0.00 |
| CareCloud (CCLD) | United States | $0.090B | 6.42 |
| P3 Health Partners (PIII) | United States | $0.082B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.071B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.061B | 0.00 |
| Pulmonx (LUNG) | United States | $0.054B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.043B | 0.00 |
| Precipio (PRPO) | United States | $0.042B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| 111 (YI) | China | $0.033B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.029B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.025B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.019B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.000B | 0.00 |